HIV, AIDS and Trump
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...
The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...
Trump’s pause in USAID spending has put major African HIV vaccine and prevention trials on hold, leaving the research world ...
A summary of current health news highlights a bird flu outbreak in Canada, halted HIV vaccine trials in South Africa, a legal ...
Supercomputer simulations have revealed how changes in the shape of the HIV-1 capsid protein may help the virus squeeze its ...
Veteran vaccine researcher Arturo Casadevall gives a podcast primer on vaccinations, from how they work on a molecular level to common misconceptions ...
Advancements in medicine and public health strategies continue to reshape the HIV landscape. The future of prevention lies in expanding access to innovative treatment options and developing new ...
Vaccine critic Robert F. Kennedy Jr. was confirmed as the new US health secretary on3, 2025. His nomination in mid-November led to a resurgence of claims that question the efficacy of vaccines. Posts ...
Trump’s aid cut has also hit clinical trials. The South African Medical Research Council, which was awarded $45 million to ...
Updated Hep B Vaccine More Effective for People With HIV Dec. 10, 2024 — A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective ...
The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results